578 results on '"Wahl, Denis"'
Search Results
52. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature
53. Neural Network Diagnoses the Antiphospholipid Syndrome without Interrupting Anticoagulant Therapy
54. Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”)
55. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study
56. The mediating effect of fatigue in impaired quality of life in systemic lupus erythematosus: mediation analysis of the French EQUAL cohort.
57. Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses
58. Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
59. Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies
60. Highlights from 2022 in EHJ Open
61. TaSER: Combining forces to stop the clot
62. Supplemental Material - Risk of livedo with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis
63. Supplemental Material - Antiphospholipid syndrome in patients over 65 years: A comparative study of clinical and biological features and thrombotic relapses
64. Pulmonary Hypertension in Antiphospholipid Syndrome
65. Hyperhomocystéinémie et thromboses artérielles
66. Liste des collaborateurs
67. Atteinte artérielle du syndrome des antiphospholipides
68. Calibrated automated thrombography demonstrates hypercoagulability in patients with idiopathic pulmonary arterial hypertension
69. Direct Oral Anticoagulants Use in Antiphospholipid Syndrome: Are These Drugs an Effective and Safe Alternative to Warfarin? A Systematic Review of the Literature: Response to Comment
70. Les TIH « auto-immunes » (aHIT)
71. Validity of the global anti-phospholipid syndrome score to predict thrombosis: a prospective multicentre cohort study
72. Responsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLE
73. Circulating Endothelial Cells are Associated with Thromboembolic Events in Patients with Antiphospholipid Antibodies.
74. Valvular Heart Disease in Antiphospholipid Syndrome
75. Risk of thrombosis, pregnancy morbidity or death in antiphospholipid antibodies positive patients with or without thrombocytopenia
76. Chapitre 151 - Fibrinolytiques
77. Chapitre 135 - Complications vasculaires de l’homocystinurie
78. Chapitre 134 - Hémoglobinurie paroxystique nocturne
79. Chapitre 133 - Syndrome des antiphospholipides
80. Chapitre 76 - Artériopathies infectieuses
81. Chapitre 59 - Dissection des artères digestives
82. Chapitre 51 - Artériopathie athéromateuse des artères digestives
83. Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
84. A new pro-thrombotic mechanism of neutrophil extracellular traps in antiphospholipid syndrome: impact on activated protein C resistance
85. A Giant Abdominal Aortic Aneurysm Revealing a Marfan Syndrome With a New FBN1 Mutation
86. Inhibition of the mTORC Pathway in the Antiphospholipid Syndrome
87. INITIAL PROFILE OF POSITIVITY AND PERSISTENCE OF ANTIPHOSPHOLIPID ANTIBODIES AFTER A PERIOD OF TWELVE WEEKS: O20
88. Corrigendum to “Antiphospholipid antibodies and the risk of thrombocytopenia in patients with systemic lupus erythematosus: A systematic review and meta-analysis” [AUTREV 18–11 (2019) 102395]
89. Mechanisms of antiphospholipid-induced thrombosis: Effects on the protein C system
90. Additional file 5 of Cardiovascular and connective tissue disorder features in FLNA-related PVNH patients: progress towards a refined delineation of this syndrome
91. Ophthalmologic manifestations in patients with antiphospholipid antibodies: Beware of iatrogenic complications
92. Attitude des médecins vasculaires vis-à-vis de la contraception lors d’un événement thrombotique veineux en contexte hormonal
93. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis Update of the guidelines for lupus anticoagulant detection and interpretation
94. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
95. Test de génération de thrombine La thrombinographie: Méthodologie
96. Concomitant myocardial injury and valvular disease in Sneddon syndrome: a case report
97. Recommendations for the measurement of thrombin generation: Communication from the ISTH SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies
98. Primary Adrenal Insufficiency Due to Bilateral Adrenal Hemorrhage-Adrenal Infarction in the Antiphospholipid Syndrome: Long-Term Outcome of 16 Patients
99. Liste des auteurs
100. Liste des Auteurs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.